EMA/ICH - The ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage forms has been adopted
The ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage forms has been fully adopted on 23 July 2024. This guideline is intended to provide recommendations on conducting bioequivalence (BE) studies during both development and post-approval phases for orally administered immediate-release (IR) solid dosage forms designed to deliver drugs to the systemic circulation, such as tablets, capsules, and granules/powders for oral suspension. Deviations from the recommendation...
Publication Details
- Journal
- Industrias Culturais (Universidade de Coimbra)
- Published
- 2024-10-19
- DOI
- https://doi.org/10.58079/12j9d
- Primary Topic
- Drug Solubulity and Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00